Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04976933 · ClinicalTrials.gov registry record
Post-HSCT Medication Adherence mHealth App
A clinical trial of Stem Cell Transplantation, sponsored by Micah Skeens.
- Completed
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT04976933: Completed study of Stem Cell Transplantation, sponsored by Micah Skeens.
NCT04976933 is a study of Stem Cell Transplantation that has completed, run by Micah Skeens. The registered enrollment target is 15 participants, below the 43-participant average among 8 other Stem Cell Transplantation trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04976933, a study of Stem Cell Transplantation, has completed, sponsored by Micah Skeens.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Through a mixed methods, quasi-experimental design, the study will first focus on developing a mobile health (mHealth) adherence application and evaluating usability and acceptability of the app among caregivers of children in the acute phase post-HSCT. The purpose of this project is to explore the feasibility and acceptability of a mHealth application through user testing and thematic content analysis.
Primary Outcome
The SUS is a 10-item questionnaire used to evaluate the functionality and acceptability of mHealth apps. Items are rated on a 5 point scale and final scores on the measure range from 0 to 100. Higher scores represent better functionality and acceptability. Scores of \> 68 are considered above average.
Conditions Studied
Interventions
- BEHAVIORAL mHealth adherence app
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-09-15 |
| Est. Completion | 2023-01-31 |
What the finished NCT04976933 record still lists
NCT04976933 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 43-participant average among 8 other Stem Cell Transplantation trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Stem Cell Transplantation appearing as the primary indexed condition, and to 1 intervention - of which mHealth adherence app is the first listed.
NCT04976933 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04976933 about?
NCT04976933 is a clinical study titled "Post-HSCT Medication Adherence mHealth App". Through a mixed methods, quasi-experimental design, the study will first focus on developing a mobile health (mHealth) adherence application and evaluating usability and acceptability of the app among caregivers of children in the acute phase post-HSCT. The purpose of this project is to explore the ...
What is the current status of trial NCT04976933?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2021-09-15. Estimated completion is 2023-01-31.
What conditions does trial NCT04976933 study?
This clinical trial studies the following conditions: Stem Cell Transplantation.
What interventions are being tested in trial NCT04976933?
The interventions under investigation include: mHealth adherence app (BEHAVIORAL).
Who is sponsoring clinical trial NCT04976933?
This trial is sponsored by Micah Skeens, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04976933 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stem Cell Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04976933's enrollment target sits among peer trials
15 9th of 8 the lowest of 8 other Stem Cell Transplantation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stem Cell Transplantation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation
ACTIVE NOT RECRUITING · NA
-
Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure
ACTIVE NOT RECRUITING · Phase 2
-
Feasibility Neurocognitive Outcome After Transplant
ACTIVE NOT RECRUITING · NA
-
C-Reactive Protein as a Predictor of Stem Cell Transplant Complications
COMPLETED
-
Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation
COMPLETED · Early Phase 1
-
The Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis Pilot Study (The POSEIDON-Pilot Study)
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI